Ontology highlight
ABSTRACT:
SUBMITTER: Zeidan AM
PROVIDER: S-EPMC7732188 | biostudies-literature | 2020 Feb
REPOSITORIES: biostudies-literature
Zeidan Amer M AM Hu Xin X Zhu Weiwei W Stahl Maximilian M Wang Rong R Huntington Scott F SF Giri Smith S Bewersdorf Jan Philipp JP Podoltsev Nikolai A NA Gore Steven D SD Ma Xiaomei X Davidoff Amy J AJ
Leukemia & lymphoma 20191001 2
Population level survival of patients with myelodysplastic syndromes (MDS) treated with hypomethylating agents (HMA) is inferior to clinical trials. Using SEER-Medicare data, we identified 2086 MDS patients diagnosed in 2004-13, aged ≥66 years at diagnosis, and receiving ≥1 HMA cycle after 2005. We used multivariate logistic regression and Cox proportional hazards models to assess the impact of provider experience on persistent HMA therapy and overall survival (OS), respectively. Median number o ...[more]